Ondřej Toman
Masaryk University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ondřej Toman.
Heart Rhythm | 2015
Martin Fiala; Veronika Bulková; Libor Škňouřil; Renáta Nevřalová; Ondřej Toman; Jaroslav Januška; Jindřich Špinar; Dan Wichterle
BACKGROUND The impact of restoring sinus rhythm (SR) by initial ablation in patients with long-standing persistent atrial fibrillation (LSPAF) is not fully established. OBJECTIVE The purpose of this study was to investigate the prognostic value of SR restoration at the initial procedure and arrhythmia noninducibility at the final repeat procedure for long-term outcome. METHODS A total of 203 patients (22% female; age 59 ± 9 years) underwent stepwise catheter ablation for LSPAF. RESULTS The procedural end-point of SR restoration was achieved in 50% of patients. During follow-up (median 48 months) and after 1.7 procedures per patient, 72% of patients were free from arrhythmia off antiarrhythmic drugs. Failure to restore SR was independently predicted by left atrial (LA) long-axis diameter ≥68 mm (relative risk [RR] 1.55, P = .03], proportion of high-voltage LA sites <20% (RR 1.62, P = .02), and left atrial appendage (LAA) atrial fibrillation cycle length (AFCL) <155 ms (RR 1.5, P = .05). Arrhythmia recurrence after the initial procedure was predicted by SR nonrestoration (RR 2.99, P <.000001) and LAA AFCL ≥155 ms (RR 1.90, P = .0002). Arrhythmia recurrence after the final procedure was predicted by SR nonrestoration at the initial procedure (RR 2.83, P = .0007), persistent AF duration ≥24 months (RR 2.74, P = .002), LAA outflow velocity <40 cm/s (RR 2.21, P = .006), and LAA AFCL ≥155 ms (RR 1.92, P = .02). In 115 patients with repeat procedure(s), failure to achieve arrhythmia noninducibility at the final procedure (19% of patients) was associated with arrhythmia recurrence (RR 8.9, P < .000001). CONCLUSION SR restoration at the initial procedure and arrhythmia noninducibility at the last repeat procedure were major predictors of arrhythmia-free outcome after ablation for LSPAF.
Europace | 2016
Martin Fiala; Veronika Bulková; Libor Škňouřil; Renáta Nevřalová; Ondřej Toman; Jaroslav Januška; Jindřich Špinar; Dan Wichterle
Aims Identifying patients who benefit from restored sinus rhythm (SR) would optimize the selection of candidates for ablation of long-standing persistent atrial fibrillation (LSPAF). This prospective study sought to identify the hitherto unknown factors associated with global functional improvement after successful radiofrequency catheter ablation of LSPAF. Methods and results In 171 LSPAF patients (84% of the total consecutive 203 patients) who were examined in SR 12 months after ablation, the individual per cent change from baseline value in maximum oxygen consumption at exercise test (VO2 max), left ventricular ejection fraction (LVEF), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), and five-dimensional descriptive system (EQ-5D) of quality-of-life questionnaire were classified in quartiles by 0 (worse) to 3 (best) grades. The individual grades were summed into a composite score (SCORE, 0 … 12) reflecting global functional improvement. Significant improvement in VO2 max (3.4 ± 4.7 mL/kg/min), LVEF (7.5 ± 9.1%), NT-proBNP (-861 ± 809 pg/mL), and EQ-5D (0.7 ± 0.12) was observed (all P < 0.0001). On multivariable analysis, younger age (P = 0.001), male gender (P = 0.02), timely post-ablation left atrial appendage (LAA) outflow (P = 0.005) with improvement in outflow velocity (P = 0.0002), and withdrawal of Class I/III antiarrhythmic drugs (P < 0.05) were positively and independently correlated with the SCORE. Conclusions Younger male patients benefited most from catheter ablation of LSPAF. Delayed or non-improved LAA outflow and inability to discontinue Class I/III antiarrhythmic medication reduced the post-ablation functional improvement.
Europace | 2014
Martin Fiala; Dan Wichterle; Veronika Bulková; Libor Škňouřil; Renáta Nevřalová; Ondřej Toman; Miloslav Dorda; Jaroslav Januška; Jindřich Špinar
Physiological Research | 2008
Martina Raudenská; Alexandra Bittnerová; Tomáš Novotný; Alena Floriánová; Karel Chroust; Renata Gaillyová; Bořivoj Semrád; Jitka Kadlecová; Martina Šišáková; Ondřej Toman; Jindřich Špinar
Vnitr̆ní lékar̆ství | 2006
Tomáš Novotný; Kadlecová J; Papousek I; Karel Chroust; Bittnerová A; Floriánová A; Eva Češková; Weislamplová M; Pálenský; Sisáková M; Ondřej Toman; Gaillyová R; Jindrich Spinar
Vnitr̆ní lékar̆ství | 2006
Sisáková M; Ondřej Toman; Floriánová A; Kadlecová J; Karel Chroust; Papousek I; Jindrich Spinar
Vnitr̆ní lékar̆ství | 2012
Kateřina Helánová; Jiří Pařenica; Jiří Jarkovský; L. Dostálová; Simona Littnerová; Klabenešová I; Zdeňka Čermáková; Petr Lokaj; Petr Kala; Martin Poloczek; Ondřej Toman; Gimunová O; Jan Maláska; Jindřich Špinar
Cor et vasa | 2012
Martin Fiala; Libor Škňouřil; Ondřej Toman; Jakub Pindor; Veronika Bulková; Radek Neuwirth; Růžena Lábrová; Jaroslav Januška; Jindřich Špinar
Vnitr̆ní lékar̆ství | 2011
Parenica J; Petr Kala; Jiří Jarkovský; Martin Poloczek; Ondřej Toman; Monika Pávková Goldbergová; Manousek J; Krystyna Prymusová; Lenka Kubková; Martin Tesák; Elbl L; Zdeňka Čermáková; Jindřich Špinar
Vnitr̆ní lékar̆ství | 2011
Fiala M; Chovancik J; Wojnarová D; Bulková; Pindor J; Szymeczek H; Růžena Lábrová; Ondřej Toman; Januska J; Jindrich Spinar